Abstract
Ultraviolet-B (UVB) is one of the most cytotoxic and mutagenic stresses that contribute to skin damage and aging through increasing intracellular Ca2+ and reactive oxygen species (ROS). Derinat (sodium deoxyribonucleate) has been utilized as an immunomodulator for the treatment of ROS-associated diseases in clinics. However, the molecular mechanism by which Derinat protects skin cells from UVB-induced damage is poorly understood. Here, we show that Derinat significantly attenuated UVB-induced intracellular ROS production and decreased DNA damage in primary skin cells. Furthermore, Derinat reduced intracellular ROS, cyclooxygenase-2 (COX-2) expression and DNA damage in the skin of the BALB/c-nu mice exposed to UVB for seven days in vivo. Importantly, Derinat blocked the transient receptor potential canonical (TRPC) channels (TRPCs), as demonstrated by calcium imaging. Together, our results indicate that Derinat acts as a TRPCs blocker to reduce intracellular ROS production and DNA damage upon UVB irradiation. This mechanism provides a potential new application of Derinat for the protection against UVB-induced skin damage and aging.
Keywords: Derinat, UVB, ROS, calcium, TRPCs
1. Introduction
Ultraviolet radiation (UVR) is the major etiologic factor for skin aging and its associated diseases and symptoms, such as wrinkles, epidermal pigmentation, melanin production and cancers [1]. Among the three types of UVR in sunlight, ultraviolet-B (UVB, radiation 280–320 nm) is the most cytotoxic and mutagenic stress electro-magnetic wave, and contributes to skin damage and aging [2,3]. Because the energy of UVB is sufficient to generate reactive oxygen species (ROS) in living tissue, UVB causes DNA impairment and tumorigenesis in skin associated with intracellular Ca2+ elevation [4,5]. However, these findings have all been independently established. Currently, the molecular and cellular links between ROS generation and intracellular Ca2+ elevation in living cells are not well understood. Although a large number of compounds and drugs have been developed to investigate the mechanism of UVB-induced skin damage due to ROS and Ca2+ elevation [6,7,8,9], acceptable models to explain relationships among UVB, Ca2+ entry, DNA and cellular damage are lacking because models of cellular ROS signaling remain scattered in the fields of biochemistry and physiology. Due to the disconnection between in vitro and in vivo experimental results that preclude direct comparisons, it is difficult to explain the toxic effect of UVB on skin by these scattering models. In addition, the application of several types of damage-suppressing reagents has been attempted (application to medium) in vitro and indirectly attempted (intra-vascular injection) in vivo. Thus, to reconcile fundamental differences between in vivo and in vitro experimental results, we attempted to identify a suitable reagent to study the molecular mechanism by which UVB induces skin damage and aging.
Derinat (sodium deoxyribonucleate), is a popular clinical drug with a long history and use experience in Russia. It contains DNA sodium salt isolated from the soft roes of Acipenser gueldenstaedtii (Russian sturgeon), which is depolymerized in 0.1% sodium chloride solution to particles with the molecular weight of 270–500 KDa through the utilization of ultrasound [10]. Clinical studies have shown that Derinat has a unique immunomodulatory function that is applicable for the treatment of pathogenesis, sepsis, inflammatory conditions and ulcers [11,12,13,14,15,16]. For example, in a study of rheumatoid arthritis, Derinat was found to suppress tumor necrosis factor alpha (TNF-α) and accelerate lymphocyte blast transformation in rats [17]. Derinat was also utilized as a clinical therapeutic against various infections, inflammatory conditions and ulcers, which are correlated with ROS production [18,19,20]. However, most of the molecular mechanisms by which Derinat functions remain unclear. Thus, Derinat would be a good candidate reagent to understand the repair mechanisms of UVB-induced cellular damage in vivo and in vitro.
Here, we hypothesized that Derinat protects skin from UVB-induced damage by inhibiting intracellular Ca2+ elevation induced by the transient receptor potential (TRP) channels. Our study identified the underlying mechanisms by which Derinat protects the skin from the UVB-induced destruction of skin in vitro and in vivo. To this end, we utilized keratinocytes (KCs) and human dermal fibroblasts (HDF) from human foreskin and then examined the UVB-induced impairment of the skin in vitro. Furthermore, for the in vivo studies, we determined UVB-induced skin injury symptoms in nude mice. Our results revealed that Derinat significantly protected not only skin cells, but also the epidermis of nude mice from UVB-induced damage. Taken together, these results suggest that Derinat reduces skin aging by depressing intracellular Ca2+ elevation and may be useful to prevent/treat age-associated diseases/symptoms.
2. Results and Discussion
2.1. Derinat Protected Skin Cells from Damage Induced by UVB Irradiation
To explore the effect of Derinat on UVB-induced skin damage, we first defined the effective dose of Derinat for ultraviolet-B (UVB) irradiation in skin cells in vitro using human keratinocytes (KCs) and human dermal fibroblasts (HDF). The skin cells were irradiated with different amounts of UVB, and the ratio of cell viability was then quantified for various radiation doses, as described in the experimental section. Figure 1A,B show that 45% of KCs and 65% of HDF survived after 50 mJ/cm2 and 100 mJ/cm2 of UVB exposure, respectively. KCs pretreated with different concentrations of Derinat for 24 h were irradiated with UVB, followed by conditioning with 15 μg/mL of Derinat for KCs (Figure 1C) and 150 μg/mL of Derinat for HDF. This approach effectively prevented UVB-induced impairment in skin cells (Figure 1D). No additional toxic effects were observed in response to Derinat treatment (Figure 1C,D). The viabilities of KCs and HDF were 70% and 78% (Figure 1E,F), respectively. These results indicated that Derinat promotes the survival ratio of KCs and HDF in response to UVB-induced damage.
2.2. Derinat Decreased Intracellular Ca2+ Elevation in Skin Cells Exposed to UVB
Previous studies indicated that UVB increased the intracellular Ca2+ concentrations and contributed to skin damage and aging [21,22]. Therefore we hypothesized that Derinat protects skin cells from UVB-induced damage by blocking intracellular Ca2+ elevation. To test this hypothesis, we measured the intracellular Ca2+ concentration via fluo-4 staining. The skin cells were exposed to UVB irradiation after Derinat pretreatment for 24 h. After 30 min of UVB irradiation, the intracellular Ca2+ concentration was observed using an Olympus fluorescence microscope with an average fluorescence intensity of more than 150 cells. The experimental protocol for each group is presented in Figure 2A, and a Ca2+ calibration curve was generated to calculate the intracellular concentration in skin cells under the microscope (Figure 2B). Figure 2C,D show that Derinat almost completely blocked the UVB-induced intracellular Ca2+ elevation in KCs, whereas it showed a smaller but statistically significant reduction in the Ca2+ elevation in UVB-treated HDF. These results suggested that Derinat blocked the UVB-induced Ca2+ elevation in both KCs and HDF cells. We also tested whether external cellular environment drives the UVB-induced increase in the intracellular Ca2+ concentration. The application of Ethylenediaminetetraacetic acid (EDTA), a chelator of extracellular Ca2+, reduced the intracellular Ca2+ concentration in a dose dependent manner in skin cells 30 min after UVB exposure (Figure 2C,D). As a result, Derinat reduces the UVB-induced Ca2+ entry from the extracellular space into the intracellular compartment. Interestingly, Derinat also attenuated Ca2+ elevation in skin cells 24 h after UVB irradiation (Figure 2E,F). Perhaps Derinat blocks the initial trigger for UVB-induced Ca2+ elevation in skin cells.
To investigate the mechanism by which Derinat blocked Ca2+ influx, skin cells were pretreated with Derinat for 30 min, and the Ca2+ influx activities were then detected with Ca2+ imaging analysis. We first used thapsigargin (TG) to raise cytosolic Ca2+ by depleting Ca2+ stores. As shown in Figure 3A,B, UVB did not affect the TG-activated Ca2+ influx in skin cells. We next determined whether the Transient Receptor Potential (TRP) superfamily of cation channels regulate UVB-activated Ca2+ entry. As diacylglycerol (DAG) activates the majority of TRP channels [23,24], and ultraviolet (UV) light irradiation increased DAG [25], a previous study hypothesized that TRP channels may contribute to UVB-induced intracellular Ca2+ elevation in skin [23]. We then detected whether the presence of cations precedes the activation of the TRP channels. As shown in Figure 3C,D, Derinat, 2-aminoethoxydiphenyl borate (2-APB) and SKF96365 [26,27] significantly decreased the Ca2+ signaling induced by a DAG analogue, membrane permeable 1-oleoyl-2-acetyl-sn-glycerol (OAG), in KCs and HDF after 30 min of UVB exposure. OAG-medicated Ca2+ peak was blocked by Derinat from 970 nM to 800 nM in KCs (Figure 3E) and from 1300 nM to 1100 nM in HDF (Figure 3F), respectively. According to Venkatachalam’s study published in 2007, transient receptor potential canonical (TRPC) channels (TRPCs), TRPV1 and TRPA1 are activated by DAG [24]. However, Figure 3C–F indicate TRPV1 and TRPA1 are not involved in UVB induced Ca2+ elevation because of no Ca2+ increase with 2-APB treatment [28,29]. Whereas Derinat and inhibitors efficiently blocked non-selective TRP agonist OAG-activated after 30 min of UVB exposure, we further confirmed whether TRPCs were activated by UVB. Adenosine triphosphate (ATP) was applied as a stimulator to induce TRPCs response, because ATP activates phospholipase-C (PLC) pathway, which leads to TRPCs open [30,31,32,33]. We firstly tested the effect of ATP on Ca2+ response in skin cells. Irradiation with UVB slightly promoted the level of ATP activated Ca2+ response while was reduced that minor via treating with Derinat, SKF96365 and 2-APB (Figure 3G–J). Thus, further attempt to demonstrate UVB activated TRPCs by PLC pathway stimulation. As shown in Figure 3K–N, Derinat and inhibitors restrained UVB-induced increase of Ca2+ influx by PLC stimulation in skin cells. Based on our results, we can’t exclude TRPM5 and TRPM7 are also involved in PLC-induced Ca2+ influx. Nevertheless, the population of TRPM5 in skin exists small amount [34]; TRPM7 can’t be activated by DAG. Therefore the exclusive interruption indicates Derinat reduces UVB-activated TRPCs in initiated stage. Interestingly, after 24 h of UVB irradiation, detection of TRPC1, TRPC4, TRPC6 and TRPC7, which are expressed in skin cell [34], UVB induced increase of TRPCs expression were also interrupted by Derinat and 2-APB, especially TRPC7 (Figure 4A,B). Based on the physicochemical features of Derinat and TRPCs, Derinat can block the activity of TRPCs in a similar manner as tetrodotoxin (TTX) blocks sodium channels [35]. However, unlike TTX, Derinat is negatively charged, and thus is unable to insert into a channel pore. Moreover, a heterogeneous DNA mixture would reduce UVB induced damage, because a topical solution would absorb the UVB radiation preventing cellular damage. Except against UVB-induced TRPCs activation, Derinat contains heterogeneous DNA may protect skin damage via absorbing the light under UVB range.
Taken together, these results suggest that Derinat acts as a TRPCs blocker to reduce intracellular Ca2+. In the future, it is important to determine which TRPCs are involved in regulation UVB-activated Ca2+ elevation by the use of each TRPC siRNA.
2.3. Derinat Reduced Oxidative Stress Accumulation Following the UVB Irradiation of Skin Cells
The first response to UVB-induced intracellular ROS generation in skin cells is an elevation of intracellular c Ca2+ [21]. Based on our results, Derinat attenuated the UVB-induced Ca2+ elevation. These results suggested that Derinat protects skin cells from UVB-induced damage by decreasing the level of Ca2+-induced intracellular ROS production by mitochondria. We tested this hypothesis by performing the following experiments: thirty minutes after UVB exposure, the level of intracellular ROS was slightly increased by 1.25-fold in KCs (Figure 5A,C). Pretreatment with Derinat or N-acetylcysteine (NAC), a intracellular ROS scavenger that that reportedly inhibits UVB-induced intracellular ROS production and DNA damage in skin cells [36], suppressed the UVB-induced increased intracellular ROS levels in KCs. Incubation with EDTA after UVB exposure also produced similar results. Interestingly, the effects of Derinat and NAC on HDF did not differ after 30 min of UVB exposure (Figure 5B,D). However, both KCs and HDF exposed to UVB showed decreased levels of intracellular ROS generation after 24 h when treated with Derinat and NAC (Figure 5E,F). The intracellular ROS production levels in KCs and HDF were quantified, which showed that Derinat attenuated the UVB-induced levels of ROS production from 2.25- to 1.67-fold and from 2.52- to 1.53-fold in KCs and HDF, respectively (Figure 5G,H). Similar results were also found in the NAC pretreatment group (Figure 5G,H). Taken together, these results clearly show that the Derinat suppressed UVB-induced intracellular ROS production by reducing the intracellular Ca2+ elevation in skin cells.
2.4. Derinat Protected Skin Cells Against UVB Induced DNA Damage
UVB-induced intracellular ROS production via the nitric oxide pathway has already been shown to contribute to nuclear and mitochondrial DNA damage, both of which are observed when 8-oxo-2’-deoxyguanosine (8-oxodG) accumulates in skin cells [37,38]. As demonstrated in our above results, Derinat may protect skin cells from UVB-induced DNA damage by decreasing the level of intracellular ROS production. Thus, we investigated the effects of Derinat on UVB-induced DNA damage. Skin cells were pretreated with Derinat or NAC for 24 h, and the ratio of DNA damage and 8-oxodG 24 h after UVB exposure was then measured. Pretreatment with Derinat and NAC reduced the ratio of DNA damage from 51% to 12% and from 51% to 23%, respectively (Figure 6A,B). Similar results were also observed in HDF, but Derinat and NAC pretreatment reduced the ratio of DNA damage to 2% and 3%, respectively (Figure 6C,D). Taken together, these results support our above findings in skin cells: Derinat protects skin cells against UVB-induced injury by suppressing intracellular Ca2+ elevation, intracellular ROS production and DNA damage, which helps skin cells to avoid skin impairment and reduces the aging potential.
2.5. Derinat Protected BALB/c-nu Mice from UVB-Induced Skin Damage
Next, we investigated whether Derinat protected animal skin from UVB-induced damage in BALB/c-nu mice by observing the desquamation, epidermal thickness, ROS production and DNA damage. Derinat is classified as a water-soluble reagent; therefore, Derinat does not easily enter skin. We cooperated with SOMAPEX BIOTECH. Co. (Kaohsiung, Taiwan) to develop a special hydrogel for Derinat (D hydrogel). Derinat hydrogel helps skin tissue absorb this drug by tuning the surface charge distribution on the pores of the skin surface [39,40]. The Derinat-containing hydrogel formed a 3-cm diameter circular chip. Three different concentrations of Derinat in hydrogels were prepared for the in vivo experiments: 0 (control), 3.5 μg/cm2 (15 μg/mL) and 14 μg/cm2 (60 μg/mL). During the experiment, the BALB/c-nu mice were mechanically immobilized. The skin of each mouse was covered with different concentrations of Derinat hydrogel for 3 h. After 3 h of treatment, the BALB/c-nu mice were irradiated with 360 mJ/cm2 UVB light [6]. After seven days, this radiation resulted in severe desquamation and erythema in the dorsal skin in BALB/c-nu mice, as indicated in Figure 7A, while 3.5 μg/cm2 and 14 μg/cm2 Derinat hydrogel mitigated this UVB-induced skin damage in animal skin. Moreover, the abdominal area of the skin of each BALB/c-nu mouse was utilized as a control, and no effect was observed in this area. Moreover, the Derinat treatment reversed the reduction of the epidermal thickness and intracellular ROS production induced by UVB (Figure 7B,C). The intracellular Ca2+ concentration can upregulate cyclooxygenase-2 (COX-2), which is known to be controlled by UVB induced inflammation [41,42]. The COX-2 expression was also expected to be increased in response to the UVB irradiation of the mouse epidermis [41]. Therefore, we tested whether Derinat also affects the COX-2 expression in skin cells. As shown in Figure 7B,D, Derinat treatment reduced the expression of COX-2. UVB-induced TRPC7 expression also decreased the level by Derinat (Figure 7E). Moreover, Derinat protects skin cells from UVB-induced DNA damage in BALB/c-nu mice (Figure 7B). To further elucidate the protective effect of Derinat on skin cells with UVB-induced DNA damage, we excised a small piece of dorsal skin and then extracted genomic DNA from it to quantify the percentage of DNA damage using an HT 8-oxodG ELISA kit II (Trevigen Inc., Gaithersburg, MD, USA). The quantitative analysis of 8-oxodG is displayed in Figure 7F, demonstrating that Derinat suppressed the UVB-induced DNA damage in a dose dependent manner in mouse skin. Taken together, our in vivo results revealed that Derinat effectively decreases the UVB-induced negative effects on skin, such as desquamation, epidermal proliferation, intracellular ROS production, DNA damage and the expression of COX-2 in BALB/c-nu mouse skin. Interestingly, the response of HDF to UVB irradiation was not as great as that of KCs based on the results presented here.
As shown in Figure 2, the intracellular Ca2+ elevation in KCs is seven times higher than that in HDF following UVB exposure. A similar tendency was also demonstrated in the ratio of ROS production and that of DNA damage in HDF. The differences between KCs and HDF may be attributed to differences in the intracellular Ca2+ elevation due to the different distribution of TRPCs between KCs and HDF for UVB-induced damage processes in the skin.
3. Experimental Section
3.1. Cell Culture
Human primary keratinocytes (KCs) and human dermal fibroblasts (HDF) were isolated from foreskins obtained via routine circumcision (with approval from the Institutional Review Board/Ethics Committee (IRB), number KMUH-IRB-960119), as described previously [43,44]. Briefly, the foreskin samples were washed using phosphate-buffered saline (PBS) (Gibco Invitrogen, Carlsbad, CA, USA) and disinfected with 70% alcohol. The harvested foreskins were minced into small pieces. To isolate the HDF, small pieces of the dermis were immersed in type I collagenase (3 mg/mL) (Sigma Chemicals Co.; St. Louis, MO, USA) and type IV collagenase (3 mg/mL) (Sigma Chemicals Co.) at 37 °C for 2 h. The samples were then incubated in 0.25% trypsin-EDTA solution (Gibco Invitrogen) at 37 °C for 30 min. The isolated HDF were grown in Dulbecco’s modified Eagle’s medium DMEM (Gibco Invitrogen) supplemented with 10% fetal bovine serum (FBS) at 37 °C in a humidified incubator containing a 5% CO2-in-air atmosphere. To isolate KCs, the small pieces of foreskin sample were treated with 1 U/mL dispase II (neutral protease) (Gibco Invitrogen) at 4 °C overnight. The epidermis was then separated from the foreskin sample and incubated in 0.25% trypsin-EDTA solution at 37 °C for 15 min. The isolated KCs were cultured in Keratinocyte-SFM medium (Gibco Invitrogen) at 37 °C in a humidified incubator containing a 5% CO2-in-air atmosphere. The medium was changed every 3 days.
3.2. Cell Viability Assay
Skin cells, 2 × 105 KCs or 1 × 105 HDF, were spread on 35-mm diameter dishes. Derinat (Technomedservia Pharmaceutical Company, Mironovskaya, Russia) was applied after the cells had spread on the dishes for 2 h, then incubated for 24 h at 37 °C in humidified 5% CO2. Skin cells were irradiated with 50 mJ/cm2 in KCs and 100 mJ/cm2 in HDF by UVB (UV source, 5 × 8-watt, 312 nm; BLX-312, Vilber Lourmat, France) and replacing normal medium for incubating 24 h. The ratios of the viabilities of skin cells were determined using 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) (Sigma Aldrich, St. Louis, MO, USA) at 570 nm in an ELISA reader [45].
3.3. Calcium Imaging
The intracellular Ca2+ responses were induced by applying thapsigargin (TG) (Sigma Aldrich), 1-oleoyl-2-acetyl-sn-glycerol (OAG) (Sigma Aldrich) and adenosine triphosphate (ATP) (Sigma Aldrich), according to previously described methods [44]. Before the experiments, cells were incubated with 1 μM Fluo-4-AM (Molecular Probes, Eugene, OR, USA) at 37 °C for 20 min and then washed with a balanced salt solution (BSS) buffer (5.4 mM KCl, 5.5 mM d-glucose, 1 mM MgSO4, 130 mM NaCl, 20 mM Hepes pH 7.4, and 2 mM CaCl2). Intracellular Ca2+ concentrations were calculated due to the ratio of fluorescence intensities emitted upon excitation with consecutive 3-s pulses of 488-nm light at a resolution of 1376 × 1038 pixels using an Olympus Cell^R IX81 fluorescence microscope (Olympus, Tokyo, Japan) equipped with an MT 20 illumination system (Olympus) and UPLanApo 10× objective lens. The intracellular Ca2+ concentration was measured based on calibration curves as follows. A Ca2+ calibration curve was created using a Ca2+ Calibration Buffer kit (Molecular Probes). Intracellular Ca2+ ([Ca2+]i) was estimated from Fluo-4 excited at 488 nm and imaged using an Olympus Cell^R IX81 fluorescence microscope and UPLanApo 10× objective lens at 20 °C. Fluo-4 signals were calibrated by measuring the fluorescence intensity from microcuvettes containing 10 mM K2-EGTA (pH 7.20) buffered to various [Ca2+] levels. Ca2+ concentration was analyzed using the following formula: [Ca2+]i = KD × (F − Fmin/Fmax − F). Plotting the fluorescence intensity versus [Ca2+] yielded the calibration curve with the formula of: [Ca2+]i = KD × (F − Fmin/Fmax − F), where KD = 345 nM, F = Fluo-4 intensity, Fmax = 640, and Fmin = 21.7 for Fluo-4.
3.4. Immunofluorescence Assay
The ratio of the DNA damage marker 8-oxodG was determined with an immunofluorescence assay using an antibody against 8-oxodG (Merck Millipore, Darmstadt, Germany). KCs and HDF were treated with or without Derinat and were cultured on 24 mm coverslips in 35 mm 6-well plates. After 24 h, cells were irradiated with 50 mJ/cm2 and 100 mJ/cm2 by UVB respectively, then replaced normal medium for incubating 24 h. After three washes with PBS, the cells were fixed by incubation with BD Cytofix for 10 min. The fixed cells were then briefly washed with PBS and incubated overnight at 4 °C in PBS containing 5% goat serum and 1% BSA with the appropriately diluted monoclonal antibody, 8-oxodG. After three washes with PBS, the cells were incubated for 1 h at room temperature with Alexa 488-conjugated goat anti-mouse IgM (Invitrogen) for 8-oxodG. The coverslips were washed three times with PBS (5 min each) and counterstained with 500 ng/mL 4,6-diamidino-2-phenylindole (DAPI, Sigma Aldrich) for 3 min. The coverslips were slide-mounted with antifade mounting solution and imaged using an Olympus FV1000 laser-scanning microscope (Olympus).
3.5. Analysis of Intracellular ROS Production in Skin Tissue
The animal experiments as affidavit of approval of animal use protocol Kaohsiung Medical Univerity, IACUC approval number: 101119. Briefly, we cooperated with SOMAPEX BIOTECH. CO. (Kaohsiung, Taiwan) to develop a special hydrogel for Derinat (Derinat hydrogel). Then male BALB/c-nu mice (6 weeks old) were purchased from the National Laboratory Animal Breeding and Research Center (Taipei, Taiwan). There were two mice in each group (three independent experiments) covered with Derinat hydrogel or pure hydrogel for 3 h and then irradiated with 360 mJ/cm2 UVB. After seven days treatment, a small section of skin tissue was excised from the dorsal area in BALB/c-nu mice and stained with 5 μM DHE (dye for staining intracellular ROS) for 30 min. After staining, the skin tissue was embedded in 1.5% low gelling agarose, sectioned into 100 μm slices with a DSK Microslicer (DTK-1000, TED PELLA, INC., Redding, CA, USA) and mounted on coated slides. The intracellular ROS production in skin tissue was observed with an Olympus FV1000 laser-scanning microscope.
3.6. Immunohistochemistry of Skin Tissue
Briefly, the dorsal skin from BALB/c-nu mice was fixed and embedded in paraffin. The monoclonal antibody of 8-oxo-2′-deoxyguanosine (8-oxodG) (Merck Millipore, 1:200) [46] and polyclonal antibody of cyclooxygenase (COX)-2 (Abcam, Cambridge, UK, 1:500) were used as previously described [6]. The immunoreactivity was visualized by incubation with DAB substrate-chromogen solution (DAKO) according to the manufacturer’s protocol.
3.7. Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR)
Total RNA was extracted from the dorsal skin of BALB/c-nu mice with the Trizol reagent (Invitrogen). Reverse-transcriptase reactions required 1 μg RNA to synthesize complementary cDNA using an RT kit (Invitrogen). Incubation conditions included 10 min at 25 °C, 120 min at 37 °C, and 5 min at 85 °C. The resulting cDNAs were utilized to detect TRPC7 expression level by the quantitative PCR using SybrGreen PCR Master Mix Kit (Applied Biosystems, Carlsbad, CA, USA) and specific primers: human TRPC1 (GenBank accession number, NM_003304), forward: TAG TGA CGA GCC TCT TGA CAA and reverse: CTG GCA GTT AGA CTG GGA GA; human TRPC4 (GenBank accession number, NM_003306), forward: CTC GCT GGT ACG ATG AGT TTC and reverse: GTG GGC TTT TGG GAG CTA TCA; human TRPC6 (GenBank accession number, NM_004621), forward: GTG ATC GCT CCA CAA GCC TAT and reverse: CTG CCA ACT GTA GGG CAT TCT; human TRPC7 (GenBank accession number, NM_001167576), forward: CGA GAA ACA GCG GAA AGA CTC and reverse: TCT GGC TAA CTC GTT GCT GAG; human GAPDH (GenBank accession number, NM_ 002046), forward: TGC ACC ACC AAC TGC TTA GC and reverse: GGC ATG GAC TGT GGT CAT GAG; mouse TRPC7 (GenBank accession number, NM_012035), forward: AAC CTG ACA GCC AAT AGC ACC TTC and reverse: TGG GCC TTC AGC ACG TAT CTC; mouse GAPDH (Gene Bank accession number, NM_001001303), forward: TGT GTC CGT CGT GGA TCT GA and reverse: TTG CTG TTG AAG TCG CAG GAG [47]. Thermal cycling was employed on the Applied Biosystems 7900HT fast real-time PCR system using the following cycling conditions: 95 °C for 10 min, and 40 cycles at 95 °C for 5 s, and 60°C for 30 s. Each complete amplification stage was followed by a dissociation stage at 95 °C for 15 s and 60 °C for 30 s.
3.8. Statistical Analysis
GraphPad Prism (La Jolla, CA, USA) was used to generate bar charts; error bars indicate standard deviations. A one-way, two-tailed analysis of variance (ANOVA) was also utilized to compare the means of each group. A p-value of less than 0.05 for differences between groups was considered statistically significant.
4. Conclusions
Our findings demonstrate that water soluble sodium deoxyribonucleate (Derinat), protects skin cells from UVB-induced damage by suppressing TRPCs-activated Ca2+ entry. The inhibition of intracellular Ca2+ elevation also contributed significantly to the decreased level of intracellular ROS production by mitochondria, which mitigated DNA damage in skin cells. The results of the in vivo experiments further supported that Derinat attenuated intracellular ROS production, COX-2 expression and DNA damage in the skin of BALB/c-nu mice exposed to UVB for seven days. Therefore, Derinat attenuates UVB-induced damage and has a great potential for the treatment of age-associated diseases or symptoms. This compound had no observable side effects, which makes it suitable for a myriad application in the fields of health and medicine.
Acknowledgments
We appreciate Helen Korneva and the late Elena Rybakina (Russian Academy of Medical Sciences, St. Petersburg, Russia) for supplying Derinat. We also appreciate the Center for Research Resources and Development at Kaohsiung Medical University for providing the use of the confocal microscope and Olympus Cell^R IX81 fluorescence microscope. This work was supported by the slow aging program, “Aim for the Top Universities Grant” (KMU-TP104G00, KMU-TP104G01 & KMU-TP104D04) at Kaohsiung Medical University, and the Ministry of Science and Technology of Taiwan, MOST, 104-2314-B-037-003 and 104-2314-B-037-060. A part of this funding was supported by Glyen-Po Chen and Grants-in Aid for Scientific Research (KAKENHI) from Japan Society for the Promotion of Science (JSPS), No. 26506022 to manuscript.
Author Contributions
Tohru Yoshioka, Shian-Jang Yan, Mami Noda and Wen-Li Hsu conceived and designed the study. Ming-Hsien Tsai performed the statistical analysis. Hsin-Su Yu, Wen-Li Hsu, Jian-He Lu and Jiadai Liu did the experimental work, analyzed the data and interpreted results. Wen-Li Hsu and Ching-Ying Wu wrote the paper and Manabu Sakakibara helped with English, with concepts and revised it critically. Finally, Mami Noda, Shian-Jang Yan, Ming-Wei Lin and Yaw-Bin Huang reviewed all the manuscript and the final version to be submitted.
Conflicts of Interest
The authors state no conflict of interest.
Footnotes
Sample Availability: Samples of the compound Derinat is available from the authors.
References
- 1.Akhalaya M.Y., Maksimov G.V., Rubin A.B., Lademann J., Darvin M.E. Molecular action mechanisms of solar infrared radiation and heat on human skin. Ageing Res. Rev. 2014;16:1–11. doi: 10.1016/j.arr.2014.03.006. [DOI] [PubMed] [Google Scholar]
- 2.Ji C., Yang Y.L., Yang Z., Tu Y., Cheng L., Chen B., Xia J.P., Sun W.L., Su Z.L., He L., et al. Perifosine sensitizes UVB-induced apoptosis in skin cells: New implication of skin cancer prevention? Cell. Signal. 2012;24:1781–1789. doi: 10.1016/j.cellsig.2012.05.003. [DOI] [PubMed] [Google Scholar]
- 3.Grether-Beck S., Felsner I., Koehler T., Farwick M., Lersch P., Rawlings A.V., Krutmann J. Topical ceramides neither enhance UVB-induced apoptosis in normal human keratinocytes nor affect viability in UVB-irradiated reconstructed human epidermis. Exp. Dermatol. 2014;23:853–855. doi: 10.1111/exd.12526. [DOI] [PubMed] [Google Scholar]
- 4.Kulms D., Schwarz T. Independent contribution of three different pathways to ultraviolet-B-induced apoptosis. Biochem. Pharmacol. 2002;64:837–841. doi: 10.1016/S0006-2952(02)01146-2. [DOI] [PubMed] [Google Scholar]
- 5.Darvin M.E., Gersonde I., Albrecht H., Sterry W., Lademann J. In vivo Raman spectroscopic analysis of the influence of UV radiation on carotenoid antioxidant substance degradation of the human skin. Laser Methods Biol. Med. 2006;16:833–837. doi: 10.1134/S1054660X06050148. [DOI] [Google Scholar]
- 6.He Y.D., Liu Y.T., Lin Q.X., Zhu J., Zhang Y., Wang L.Y., Ren X.L., Ye X.Y. Polydatin suppresses ultraviolet B-induced cyclooxygenase-2 expression in vitro and in vivo via reduced production of reactive oxygen species. Br. J. Dermatol. 2012;167:941–944. doi: 10.1111/j.1365-2133.2012.10951.x. [DOI] [PubMed] [Google Scholar]
- 7.Mukherjee P.K., Maity N., Nema N.K., Sarkar B.K. Bioactive compounds from natural resources against skin aging. Phytomed. Int. J. Phytother. Phytopharm. 2011;19:64–73. doi: 10.1016/j.phymed.2011.10.003. [DOI] [PubMed] [Google Scholar]
- 8.Hwang Y.P., Kim H.G., Han E.H., Choi J.H., Park B.H., Jung K.H., Shin Y.C., Jeong H.G. N-Acetylglucosamine suppress collagenases activation in ultraviolet B-irradiated human dermal fibroblasts: Involvement of calcium ions and mitogen-activated protein kinases. J. Dermatol. Sci. 2011;63:93–103. doi: 10.1016/j.jdermsci.2011.04.008. [DOI] [PubMed] [Google Scholar]
- 9.Tigges J., Haarmann-Stemmann T., Vogel C.F., Grindel A., Hubenthal U., Brenden H., Grether-Beck S., Vielhaber G., Johncock W., Krutmann J., et al. The new aryl hydrocarbon receptor antagonist E/Z-2-benzylindene-5,6-dimethoxy-3,3-dimethylindan-1-one protects against UVB-induced signal transduction. J. Investig. Dermatol. 2014;134:556–559. doi: 10.1038/jid.2013.362. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Sviatkina O.I., Balashov V.P., Balykova L.A., Shchukin S.A. Anti-arrhythmia activity of derinat in an experiment. Eksp. Klin. Farmakol. 2004;67:22–24. [PubMed] [Google Scholar]
- 11.Wang Y.N., Wu W., Chen H.C., Fang H. Genistein protects against UVB-induced senescence-like characteristics in human dermal fibroblast by p66Shc down-regulation. J. Dermatol. Sci. 2010;58:19–27. doi: 10.1016/j.jdermsci.2010.02.002. [DOI] [PubMed] [Google Scholar]
- 12.Gromov M.I., Pivovarova L.P. Use of immunomodulator derinat in the treatment of patients with surgical sepsis in traumatic shock. Vestn. Khir. Im. I. I. Grek. 2002;161:45–48. [PubMed] [Google Scholar]
- 13.Gora N.V., Bairakova A.L., Kozlov L.V. Enzyme immunoassay of masked complement component C4 deficiency in patients with urogenital Chlamydia infection. Zh. Mikrobiol. Epidemiol. Immunobiol. 2011;3:76–80. [PubMed] [Google Scholar]
- 14.Zemskov A.M., Zemskov V.M., Tokmakov A.I. Clinical efficacy of immunostimulating drugs in treatment of purulent infections. Khirurgiia. 2011;2:4–10. [PubMed] [Google Scholar]
- 15.Mangushev A.R., Rafailov V.V., Svatko L.G. Clinical efficiency of derinat used to treat chronic adenoiditis in children. Vestn. Otorinolaringol. 2008;6:33–34. [PubMed] [Google Scholar]
- 16.Zemskov A.M., Kiselev A.V., Koveshnikov V.V. Immune status of patients with exacerbation of chronic suppurative otitis media and its correction. Vestn. Otorinolaringol. 2010;5:38–40. [PubMed] [Google Scholar]
- 17.Leonavičienė L., Bernotienė E., Bradūnaitė R., Vaitkienė D., Redaitienė E., Astrauskas V. Antiarthritic and hepatoprotective effect of derinat on adjuvant arthritis in rats. Acta Med. Litu. 2006;13:236–244. [Google Scholar]
- 18.Paiva C.N., Bozza M.T. Are ROS always detrimental to pathogens? Antioxid. Redox Signal. 2013 doi: 10.1089/ars.2013.5447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Okayama Y. Oxidative stress in allergic and inflammatory skin diseases. Curr. Drug Targets Inflamm. Allergy. 2005;4:517–519. doi: 10.2174/1568010054526386. [DOI] [PubMed] [Google Scholar]
- 20.Handa O., Naito Y., Yoshikawa T. Helicobacter pylori: A ROS-inducing bacterial species in the stomach. Inflamm. Res. Off. J. Eur. Histamine Res. Soc. 2010;59:997–1003. doi: 10.1007/s00011-010-0245-x. [DOI] [PubMed] [Google Scholar]
- 21.Masaki H., Izutsu Y., Yahagi S., Okano Y. Reactive oxygen species in HaCaT keratinocytes after UVB irradiation are triggered by intracellular Ca(2+) levels. J. Investig. Dermatol. Symp. Proc. 2009;14:50–52. doi: 10.1038/jidsymp.2009.12. [DOI] [PubMed] [Google Scholar]
- 22.Jiang S.J., Chu A.W., Lu Z.F., Pan M.H., Che D.F., Zhou X.J. Ultraviolet B-induced alterations of the skin barrier and epidermal calcium gradient. Exp. Dermatol. 2007;16:985–992. doi: 10.1111/j.1600-0625.2007.00619.x. [DOI] [PubMed] [Google Scholar]
- 23.Hsu W. L., Yoshioka T. Role of TRP channels in the induction of heat shock proteins (Hsps) by heating skin. Biophysics. 2015;11:25–32. doi: 10.2142/biophysics.11.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Venkatachalam K., Montell C. TRP channels. Ann. Rev. Biochem. 2007;76:387–417. doi: 10.1146/annurev.biochem.75.103004.142819. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Punnonen K., Yuspa S.H. Ultraviolet light irradiation increases cellular diacylglycerol and induces translocation of diacylglycerol kinase in murine keratinocytes. J. Investig. Dermatol. 1992;99:221–226. doi: 10.1111/1523-1747.ep12650445. [DOI] [PubMed] [Google Scholar]
- 26.Rae M.G., Hilton J., Sharkey J. Putative TRP channel antagonists, SKF 96365, flufenamic acid and 2-APB, are non-competitive antagonists at recombinant human alpha1beta2gamma2 GABA(A) receptors. Neurochem. Int. 2012;60:543–554. doi: 10.1016/j.neuint.2012.02.014. [DOI] [PubMed] [Google Scholar]
- 27.Ding J., Zhang J.R., Wang Y., Li C.L., Lu D., Guan S.M., Chen J. Effects of a non-selective TRPC channel blocker, SKF-96365, on melittin-induced spontaneous persistent nociception and inflammatory pain hypersensitivity. Neurosci. Bull. 2012;28:173–181. doi: 10.1007/s12264-012-1213-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Clapham D.E. SnapShot: mammalian TRP channels. Cell. 2007 doi: 10.1016/j.cell.2007.03.034. [DOI] [PubMed] [Google Scholar]
- 29.Fajardo O., Meseguer V., Belmonte C., Viana F. TRPA1 channels: Novel targets of 1,4-dihydropyridines. Channels. 2008;2:429–438. doi: 10.4161/chan.2.6.7126. [DOI] [PubMed] [Google Scholar]
- 30.Tiruppathi C., Ahmmed G.U., Vogel S.M., Malik A.B. Ca2+ signaling, TRP channels, and endothelial permeability. Microcirculation. 2006;13:693–708. doi: 10.1080/10739680600930347. [DOI] [PubMed] [Google Scholar]
- 31.Ahmmed G.U., Malik A.B. Functional role of TRPC channels in the regulation of endothelial permeability. Pflug. Arch. Eur. J. Physiol. 2005;451:131–142. doi: 10.1007/s00424-005-1461-z. [DOI] [PubMed] [Google Scholar]
- 32.Nilius B., Owsianik G., Voets T., Peters J.A. Transient receptor potential cation channels in disease. Physiol. Rev. 2007;87:165–217. doi: 10.1152/physrev.00021.2006. [DOI] [PubMed] [Google Scholar]
- 33.Yao X., Garland C.J. Recent developments in vascular endothelial cell transient receptor potential channels. Circ. Res. 2005;97:853–863. doi: 10.1161/01.RES.0000187473.85419.3e. [DOI] [PubMed] [Google Scholar]
- 34.Toth B. I., Olah A., Szollosi A.G., Biro T. TRP channels in the skin. Br. J. Pharmacol. 2014;171:2568–2581. doi: 10.1111/bph.12569. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Vandael D.H., Ottaviani M.M., Legros C., Lefort C., Guerineau N.C., Allio A., Carabelli V., Carbone E. Reduced availability of voltage-gated sodium channels by depolarization or blockade by tetrodotoxin boosts burst firing and catecholamine release in mouse chromaffin cells. J. Physiol. 2015;593:905–927. doi: 10.1113/jphysiol.2014.283374. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Morley N., Curnow A., Salter L., Campbell S., Gould D. N-acetyl-l-cysteine prevents DNA damage induced by UVA, UVB and visible radiation in human fibroblasts. J. Photochem. Photobiol. B Biol. 2003;72:55–60. doi: 10.1016/j.jphotobiol.2003.06.004. [DOI] [PubMed] [Google Scholar]
- 37.Oikawa S. Sequence-specific DNA damage by reactive oxygen species: Implications for carcinogenesis and aging. Environ. Health Prev. med. 2005;10:65–71. doi: 10.1007/BF02897995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Rosen J.E., Prahalad A.K., Williams G.M. 8-Oxodeoxyguanosine formation in the DNA of cultured cells after exposure to H2O2 alone or with UVB or UVA irradiation. Photochem. Photobiol. 1996;64:117–122. doi: 10.1111/j.1751-1097.1996.tb02430.x. [DOI] [PubMed] [Google Scholar]
- 39.Wang S.C., Chen B.H., Wang L.F., Chen J.S. Characterization of chondroitin sulfate and its interpenetrating polymer network hydrogels for sustained-drug release. Int. J. Pharm. 2007;329:103–109. doi: 10.1016/j.ijpharm.2006.08.041. [DOI] [PubMed] [Google Scholar]
- 40.Mi F.L., Liang H.F., Wu Y.C., Lin Y.S., Yang T.F., Sung H.W. pH-sensitive behavior of two-component hydrogels composed of N,O-carboxymethyl chitosan and alginate. J. Biomater. Sci. Polym. Ed. 2005;16:1333–1345. doi: 10.1163/156856205774472317. [DOI] [PubMed] [Google Scholar]
- 41.Athar M., An K.P., Morel K.D., Kim A.L., Aszterbaum M., Longley J., Epstein E.H., Jr., Bickers D.R. Ultraviolet B(UVB)-induced cox-2 expression in murine skin: An immunohistochemical study. Biochem. Biophys. Res. Commun. 2001;280:1042–1047. doi: 10.1006/bbrc.2000.4201. [DOI] [PubMed] [Google Scholar]
- 42.Wang J.Y., Chen B.K., Wang Y.S., Tsai Y.T., Chen W.C., Chang W.C., Hou M.F., Wu Y.C., Chang W.C. Involvement of store-operated calcium signaling in EGF-mediated COX-2 gene activation in cancer cells. Cell. Signal. 2012;24:162–169. doi: 10.1016/j.cellsig.2011.08.017. [DOI] [PubMed] [Google Scholar]
- 43.Liao W.T., Yu H.S., Arbiser J.L., Hong C.H., Govindarajan B., Chai C.Y., Shan W.J., Lin Y.F., Chen G.S., Lee C.H. Enhanced MCP-1 release by keloid CD14+ cells augments fibroblast proliferation: Role of MCP-1 and Akt pathway in keloids. Exp. Dermatol. 2010;19:e142–e150. doi: 10.1111/j.1600-0625.2009.01021.x. [DOI] [PubMed] [Google Scholar]
- 44.Hsu W.L., Tsai M.H., Lin M.W., Chiu Y.C., Lu J.H., Chang C.H., Yu H.S., Yoshioka T. Differential effects of arsenic on calcium signaling in primary keratinocytes and malignant (HSC-1) cells. Cell Calcium. 2012;52:161–169. doi: 10.1016/j.ceca.2012.05.007. [DOI] [PubMed] [Google Scholar]
- 45.Hsu W.L., Chung P.J., Tsai M.H., Chang C.L., Liang C.L. A role for Epstein-Barr viral BALF1 in facilitating tumor formation and metastasis potential. Virus Res. 2012;163:617–627. doi: 10.1016/j.virusres.2011.12.017. [DOI] [PubMed] [Google Scholar]
- 46.Fujita K., Seike T., Yutsudo N., Ohno M., Yamada H., Yamaguchi H., Sakumi K., Yamakawa Y., Kido M.A., Takaki A., et al. Hydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease. PLoS ONE. 2009;4:e7247. doi: 10.1371/journal.pone.0007247. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Cheon G.J., Cui Y., Yeon D.S., Kwon S.C., Park B.G. Mechanisms of motility change on trinitrobenzenesulfonic Acid-induced colonic inflammation in mice. Korean J. Physiol. Pharmacol. 2012;16:437–446. doi: 10.4196/kjpp.2012.16.6.437. [DOI] [PMC free article] [PubMed] [Google Scholar]